|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| 27/10/21 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/08/21 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 350K 306K 282K 262K 497K 33.37M 504K 3.38M 1.31M 16.38M 1.31M 1.28M 56.79M | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39M 1.21M 1.12M 1.04M 1.97M 132M 2M 13.38M 5.21M 64.87M 5.2M 5.09M 225M | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 01/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-14 | Other | 0 | 0% | |||
| 04-14 | Other | 0 | 0% | |||
| 04-14 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 323K 283K 260K 242K 459K 30.78M 465K 3.12M 1.21M 15.11M 1.21M 1.19M 52.38M | 350K 307K 283K 262K 498K 33.42M 505K 3.38M 1.32M 16.41M 1.32M 1.29M 56.88M |
| Net income | -685K -600K -553K -513K -974K -65.37M -988K -6.62M -2.58M -32.09M -2.57M -2.52M -111M | -9.09M -7.96M -7.33M -6.81M -12.93M -867M -13.1M -87.77M -34.16M -426M -34.14M -33.39M -1.48B |
| Net Debt | 1.27M 1.12M 1.03M 954K 1.81M 122M 1.84M 12.3M 4.79M 59.64M 4.78M 4.68M 207M | 1.04M 907K 835K 775K 1.47M 98.79M 1.49M 10M 3.89M 48.49M 3.89M 3.8M 168M |
Employees
5
Sector
-
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















